Elixinol Wellness Limited
ELLXF
$0.01
$0.0092.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -212.83% | 14.11% | 71.61% | 74.72% | 77.29% |
| Total Depreciation and Amortization | -18.71% | -4.06% | 15.18% | 39.10% | 73.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 107.88% | 4,314.77% | 635.75% | -15.24% | -86.74% |
| Change in Net Operating Assets | 124.22% | -93.20% | -258.68% | -258.68% | -258.68% |
| Cash from Operations | 9.20% | 25.33% | 37.72% | 12.78% | -25.98% |
| Capital Expenditure | -7.34% | 20.94% | 50.54% | -29.15% | -406.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 94.87% | 85.02% | 70.62% | -93.91% | -1,292.27% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -101.47% | -101.17% | -100.83% | 224.72% | 277.11% |
| Cash from Investing | -215.70% | -383.45% | -256.73% | 19.86% | 93.66% |
| Total Debt Issued | 86.53% | 232.90% | 653.00% | 420.00% | 187.00% |
| Total Debt Repaid | 70.70% | 21.08% | -70.02% | -53.64% | -41.06% |
| Issuance of Common Stock | -42.31% | -44.61% | -48.01% | 16.44% | 107.07% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 39.89% | 45.78% | 54.18% | -25.42% | -183.42% |
| Cash from Financing | -8.51% | -2.58% | 8.32% | 59.93% | 136.30% |
| Foreign Exchange rate Adjustments | 1,168.18% | 554.24% | -221.15% | -236.47% | -129.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.60% | 85.14% | 66.01% | 96.55% | 117.25% |